Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | GAPDH | P04406 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13031056 | 0.92 | POLB (0.52) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL6810337 | 0.92 | POLB (0.55) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL6810335 | 0.88 | POLB (0.52) | POLBLMNAKMT2AL3MBTL1 | |
| SCHEMBL19786845 | 0.88 | LMNA (0.53) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL15592369 | 0.88 | LMNA (0.57) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL17850343 | 0.88 | LMNA (0.57) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL17850294 | 0.88 | LMNA (0.57) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13447781 | 0.88 | LMNA (0.57) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13250764 | 0.88 | LMNA (0.57) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL21097453 | 0.87 | POLB (0.79) | POLBLMNAKMT2AL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286067-A1 | GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES | BIOGENERIX AG (DE) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286067-A1 | GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES | GALNT2, GALNT6, GALNT1 | POLB 1053/4885LMNA 951/4885KMT2A 3613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.